A Relationship of Sex Hormone Levels and Erectile Dysfunction: Which Tests Should Be Done Routinely? by Müezzinoğlu, Talha et al.
Yonsei Med J 48(6):1015 - 1019, 2007
DOI 10.3349/ymj.2007.48.6.1015
Yonsei Med J Vol. 48, No. 6, 2007
Purpose: In this study, the relationship between sex
hormone levels and erectile dysfunction (ED), as well as the
necessity of routinely measuring sex hormone levels were
evaluated. Materials and Methods: This study included one
hundred patients admitted to a urology clinic for sexual
dysfunction. To determine the hormone levels, following the
history (included IIEF-5 score) and physical examination,
triple blood samples were collected at intervals of 15 minutes
between 08:00 and 10:00 am. Total and free testosterone,
prolactin, follicle stimulating hormone and luteinizing hormone
levels were studied. Results: Mean age was 43 (23 -80) years.
IIEF-5 score was less than 21 [9.8 - 4.3 (3 - 19)] in all study
groups. There was a statistically significant correlation between
tT and FSH, as well as between LH and FSH in Pearson (r
= - 0.513, p < 0.001, respectively) and also in Spearman tests
(r = - 0.224, p = 0.042 and r = -0.459, p < 0.001, respectively).
However, there was no correlation between age and serum
hormone levels (p > 0.05). Of the 100 patients, 18 (18%) had
low tT, 77 (77%) had normal and 5 (5%) had high tT levels.
No statistically significant correlation was found between
decreased libido and tT levels (p > 0.05). Twelve (66.6%) of
the 18 patients with low tT had normal libido. Conclusion:
Analyzing the medical history in detail and performing a
thorough physical examination can reduce the need for
excessive studies and consultations, and enables patients to
save time and costs.
Key Words: Hormones, diagnostic tests, erectile dysfunction,
measurement and libido
INTRODUCTION
Erectile dysfunction is defined as the inability to
achieve or maintain an erection required for
satisfactory sexual intercourse. It is a pathology
that affects men's happiness, self-esteem and
popular relations and may also contribute to
serious psychological problems.
1,2 According to
the Massachusetts Male Aging Study, the prevalence
of ED of all degrees is approximately 52% in men
between 40 and 70 years.
3 As most of the men are
reluctant to discuss ED, more than 70% of ED
cases remain undiagnosed.
4 For this reason, most
of the urologists perform an extensive screening
of the patients admitted to urology clinics for ED.
Testosterone helps regulate sexual function; it
organizes the sexual drive and stimulates masculine
behavior.
5 Testosterone is secreted episodically
from the testicular Leydig cells in response to
luteinizing hormone pulses, showing a diurnal
pattern with a peak level in the early morning and
a nadir in the evening. The unbound or active
portion of testosterone accounts for approximately
2% of the total body stores, while the remaining
98% is bound to plasma proteins, primarily al-
bumin and testosterone-estradiol-binding globu-
lin.
6 This unbound or free testosterone, which is
equal to 2%, is physiologically active, with its
effects exerted in the target cell where it may be
converted to a more potent androgen, dihydrote-
stosterone, by 5-alpha reductase. Many factors can
alter the amount of plasma proteins and, thus,
affect the amount of biologically active free
testosterone.
7 Insufficient testosterone levels lead
to a decrease in the relaxation of smooth muscle
of corpus cavernosum.
8
These diverse contributing factors necessitate
the careful analysis of several parameters for
diagnosing ED in patients. However, when the
realities of costs and time are taken into con-
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sideration, only a routine examination is usually
performed. While many of the diagnostic tests
struggle to reduce costs. It is imperative that the
evaluation remains sensitive enough to identify
individuals with treatable endocrinopathies.
7 In
this respect, in our study, the relationship
between sex hormone levels and ED, and the
necessity of measuring hormone levels routinely
for ED were evaluated.
MATERIALS AND METHODS
In this study, we evaluated 100 consecutive
patients admitted to an andrology clinic for ED.
Inclusion criteria were: being 18 years old,
having a clinically diagnosed ED for the previous
6 months as evaluated by our institution and
having a regular sexual life with a female partner.
Patients with a history of previous pelvic surgery,
pelvic irradiation, chronic neurological disease,
hypogonadism, or excess alcohol consumption, as
well as those who were on medication during the
recruitment period were excluded from the study.
All patients completed a detailed questionnaire,
the validated Sexual Health Inventory for Men
5-item questionnaire, based on the International
Index of Erectile Function questionnaire which
covered all of the aspects of erectile dysfunction
(IIEF-5).
9,10 A physician examined all of the
patients following the interview and requested the
necessary tests be performed.
Following 10 hours without food, triple blood
samples for hormone analyses were taken at
15-minute intervals between 8.00 and 10.00 AM.
11
Serum samples were kept at - 70℃ after a separa-
tion by centrifuge. Total testosterone (tT), free
testosterone (fT), prolactin (PL), follicle stimula-
ting hormone (FSH), and luteinizing hormone
(LH) levels were studied with chemiluminescent
immunoassay (ACS: 180-Chiron) and competitive
radio immunoassay-(DSL) techniques. Measuring
pituitary gonadotropins, FSH and LH can provide
reliable clues to assist the physician in deter-
mining whether it is primary or secondary hypo-
gonadism.
Based on the status of their libido, patients were
divided into two groups as the normal libido
group (n = 58) and the decreased libido group (n=
42). Libido groups were compared with age
groups using chi-square tests. In addition, again
using the chi-square test, libido groups were
compared with groups classified according to tT,
fT and PL levels. An unpaired, two-sample t-test,
one-way ANOVA, logistic regression analyses and
Spearman and Pearson's correlation analyses were
used to compare the differences among the
groups.
RESULTS
Mean age was 43 (23 - 80) years. The question-
naire took about 5 minutes to complete. IIEF-5
score was less than 21 [9.8 ± 4.3 (3 - 19)] in all
study groups, which is indicative of ED. The
IIEF-5 score was 17 to 21 in 6 of the 100 men (6%),
suggesting mild ED; 11 to 16 in 40 (40%), sug-
gesting mild to moderate ED; 8 to 10 in 18 (18%),
suggesting moderate ED, and 7 or less in 36 (36%),
suggesting severe ED.
The mean tT, fT, PL, FSH and LH levels were
14.5±7.0nmol/L (8.4- 28.7 nmol/L, normal range),
72.5 ± 46.5 pmol/L (30.1 - 189.8 pmol/L), 12.9 ± 10.1
g/L (1.6 μ - 18 g/L), 8.4 μ ± 10.9 IU/L (< 11 IU/L)
and 6.2±6IU/L (0.5- 6IU/L), respectively. There
was a statistically significant correlation between
tT and FSH and also between LH and FSH in
Pearson (r = - 0.513, p < 0.001, respectively) and
also in Spearman tests (r = - 0.224, p = 0.042 and r
= - 0.459, p < 0.001, respectively). However, there
was no correlation between age and serum
hormone levels (p > 0.05).
Table 1 lists the mean values for tT, fT, and PL,
as well as the rate of decreased libido according
to the age groups. When the patients were clas-
sified according to decreased libido, only PL
levels had a significant correlation with decreased
libido (Table 2). There was an association between
decreased libido and PL levels also on logistic
regression analysis (Not shown on the tables, p =
0.046).
Of the 100 patients, 18 (18%) had low tT, 77
(77%) had normal and 5 (5%) had high tT levels.
We did not find a significant correlation between
decreased libido and tT levels by Student's t-test
(p > 0.05). In addition to the information con-
cerning testicular atrophy from the patients'Sex Hormones In Erectile Dysfunction
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charts, the data from a questionnaire on libido
were reviewed for those patients (n = 18) with low
tT level. Since these patients had normal testicles
on examination and normal fT and PL levels, they
were not evaluated further. On the other hand, 12
(66.6%) of these 18 patients with low tT had
normal libido. The percentage of patients who had
low, normal and high hormone levels are shown
on Table 3 with respect to decreased libido.
Serum PL levels were available in 93 of our 100
patients (91.2%) and were low in 1 (1.1%), normal
in 76 (81.7%) and high in 16 (17.2%) patients.
None of these patients with a high PL level had
a pituitary pathology and 5 of these 16 patients
had a low tT (31.3%).
DISCUSSION
Understanding the dynamics of endocrine
Table 1. The Mean Values of tT, fT, PL and the Rate of Decreased Libido in According to Age Group
Age groups (n) tT fT PL Decreased libido (%)
20 - 29 (10) 18.4 71.8 20.9 4 (40)
30 - 39 (10) 15.3 85 13.3 3 (30)
40 - 49 (32) 13.9 90.2 11.5 19 (60.6)
50 - 59 (26) 14.8 54.1 13.6 9 (33.3)
60 - 69 (17) 12.3 38.1 10.9 6 (35)
≥ 70 (5) 12.4 65.9 9.7 1 (20)
Total (100) 14.5 72.5 12.9 42 (42)
p value 0.392* 0.728* 0.193* -
tT, total testosterone; fT, free testosterone; PL, prolactin.
*One way ANOVA.
Table 2. Mean Values of Age, tT, fT, PL, FSH and LH in According to Status of Libido
Libido Age (yrs) tT fT PL FSH LH
Decreased (n = 42) 47 14.7 69.4 16.5 7.6 5.3
Normal (n = 58) 50 14.2 76.3 10.2 8.9 6.8
p values > 0.05 > 0.05 > 0.05 0.002 > 0.05 > 0.05
tT, total testosterone; fT, free testosterone; PL, prolactin; FSH, follicle stimulating hormone; LH, luteinizing hormone.
Table 3. The Percentages of Patients who had a Low, Normal and High Hormone Levels in According to Status
of Libido
Libido
Low
tT*
Normal
tT*
High
tT*
Low
fT*
Normal
fT*
High
fT*
Low
PL*
Normal
PL*
High
PL*
Decreased (n = 42) 6 (14) 34 (81) 2 (5) 15 (36) 23 (55) 4 (9) - 32 (76) 10 (24)
Normal (n = 58) 12 (21) 43 (74) 3 (5) - 58 (100) - 1 (2) 50 (86) 7 (12)
p value 0.076 0.085 0.190
tT, total testosterone; fT, free testosterone; PL, prolactin.
*n (%).
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changes in the normally aging male is important
not only because of the important role hormones
play in the maintenance of sexual characteristics
and sexual activity, but also for the diagnosis and
management of endocrine and metabolic diseases.
Data concerning the influence of age on andro-
gens are inconsistent. Several researchers have
reported a decrease in free and total testosterone
concentrations, whereas others have failed to find
age-related changes in testosterone.
3,12 Although
tT seems to decline slightly with age, we could
not find any statistically significant correlation
between age groups and the values of tT and fT.
This decline with age is related to decreased
Leydig cell mass, decreased testicular perfusion
with relative hypoxia and alterations in pituitary-
hypothalamic function.
13 FSH and LH show an
increase with age, but PL has not been studied
well in men. Davidson et al and Deslypere et al
found no correlation between male PL levels and
age, while Vekemans and Robyn reported a slight
rise in PRL in 55 to 65 year-old men compared to
those 20 years younger.
14-16 In this study there was
no correlation between age and PL levels.
In hypogonadic men, impaired erection response
to visual sexual stimulation prompts considera-
tion of androgens as enhancing erection, but not
absolutely necessary.
17,18 In 1% of ED cases caused
by endocrinological problems, investigating serum
testosterone levels once is sufficient when paired
with a detailed history and physical examination.
19
Johnson and Jarrow found a low incidence of
endocrinopathy (2.1%) and noted that decreased
libido and/or testicular atrophy would predict
this condition with 100% sensitivity.
20 They
recommended laboratory testing only in patients
with decreased libido and/or testicular atrophy.
Slag et al studied 187 impotent patients and found
no correlation between libido and hypogonadism
in 35, while testicular atrophy correlated only
with primary hypogonadism.
21 In our study group
(n = 100), only 42 patients had decreased libido
and none of them had any type of endocrino-
pathy. Moreover, most of these patients had
normal values of tT (80.5%) and PL (76%).
Fahmy et al reported that it is very difficult to
establish a correlation between ED and serum
testosterone levels; and demonstrated that low
serum tT levels (< 10 nmol/mL) indicate hypo-
gonadism.
18 In the Massachusetts Male Aging
Study, testosterone levels were confirmed to de-
cline with age and free testosterone was found to
be more predictive than tT.
12 It has been suggested
that only the measurement of free testosterone is
sufficient in ED, and it is not necessary to analyze
other hormones.
7 Buvat and Lemaire recommended
measuring testosterone in all the men > 50 years
and in only those men who are < 50 years old but
having decreased libido and abnormal physical
findings.
22 But Ansong et al. found that routine
serum tT and fT measurement were not sufficient
for decreased libido and ED.
13 However, we have
found no significant correlation between ED and
the values of tT and fT.
Although it seems more likely that decreased
libido is a secondary phenomenon related to a
defence mechanism in men with ED, in the
present study, no statistically significant relation
was found between ED and libido. PL levels were
found to have a significant relation with de-
creased libido. Govier et al found a 16% incidence
of hypogonadism and 57% of this group had
neither decreased libido nor testicular atrophy.
7
Baskin reviewed 600 patients and found a 3%
incidence of hyperprolactinemia and 7 patients
had pituitary tumors (6 with low testosterone).
23
Foster et al. found a 3.9% incidence of hyper-
prolactinemia with 2 pituitary tumors.
24 One
patient with pituitary tumor had decreased libido
and decreased serum testosterone, and 1 had
decreased libido but normal serum testosterone.
In practice, performing a history and physical
examination in conjunction with measurement of
testosterone may not be sufficient to diagnose
hypogonadism or hyperprolactinemia in these
patients.
25 Moreover, testosterone levels are not
always depressed in endocrinological diseases.
18
As such, we suggest that PL should be measured
only in patients having any clinical signs and
manifestation of endocrinopathy, not in all
patients who present to a urology clinic for ED.
Measurement of hormones should be delayed
until after taking a detailed history and performing
a thorough physical examination. When these
findings were evaluated with respect to other
studies in the literature, measuring fT and
especially PL should provide adequate information.
Taking a detailed medical history and per-Sex Hormones In Erectile Dysfunction
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forming a thorough physical examination with
history can decrease the need for excessive studies
and consultations, saving patients time and un-
necessary cost.
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